TWD 24.2
(-0.21%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 2.21 Billion TWD | 12.38% |
2022 | 1.97 Billion TWD | 2.87% |
2021 | 1.91 Billion TWD | 0.3% |
2020 | 1.91 Billion TWD | 0.18% |
2019 | 1.9 Billion TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 2.17 Billion TWD | 0.0% |
2024 Q1 | 2.17 Billion TWD | -1.86% |
2023 Q3 | 2.21 Billion TWD | 14.44% |
2023 FY | 2.21 Billion TWD | 12.38% |
2023 Q1 | 1.93 Billion TWD | -1.8% |
2023 Q2 | 1.93 Billion TWD | 0.0% |
2023 Q4 | 2.21 Billion TWD | 0.0% |
2022 Q3 | 1.97 Billion TWD | 0.0% |
2022 Q4 | 1.97 Billion TWD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Allied Biotech Corporation | 2.07 Billion TWD | -6.718% |
GeneFerm Biotechnology Co., Ltd. | 1.17 Billion TWD | -88.755% |
Easywell Biomedicals, Inc. | 1.21 Billion TWD | -82.782% |
TTY Biopharm Company Limited | 9.87 Billion TWD | 77.533% |
Synmosa Biopharma Corporation | 11.72 Billion TWD | 81.084% |
Orient EuroPharma Co., Ltd. | 10.81 Billion TWD | 79.48% |
Center Laboratories, Inc. | 27 Billion TWD | 91.784% |
Tien Liang BioTech Co., Ltd. | 654.03 Million TWD | -239.213% |
Orient Pharma Co., Ltd. | 2.56 Billion TWD | 13.427% |
InnoPharmax Inc. | 524.19 Million TWD | -323.234% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 1.99 Billion TWD | -11.322% |
Excelsior Biopharma Inc. | 1.57 Billion TWD | -40.654% |
DV Biomed Co., Ltd. | 1.81 Billion TWD | -22.394% |
Foresee Pharmaceuticals Co., Ltd. | 1.86 Billion TWD | -19.186% |
Handa Pharmaceuticals, Inc. | 3.03 Billion TWD | 26.953% |
UniPharma Co., Ltd. | 350.07 Million TWD | -533.745% |
Alar Pharmaceuticals Inc. | 973.2 Million TWD | -127.966% |
Winston Medical Supply Co., Ltd. | 801.77 Million TWD | -176.708% |
Mercury Biopharmaceutical Corporation | 438.07 Million TWD | -406.437% |
Bioray Biotech Co., Ltd | 542.64 Million TWD | -308.842% |
TSH Biopharm Corporation Limited | 1.39 Billion TWD | -58.486% |